# A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model

> **NCT04105959** · PHASE1 · COMPLETED · sponsor: **Aristea Therapeutics, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Inflammatory Response

## Interventions

- **DRUG:** RIST4721
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04105959
- **Lead sponsor:** Aristea Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-25
- **Primary completion:** 2019-11-19
- **Final completion:** 2019-12-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04105959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04105959, "A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04105959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*